A history of the term "DMARD"

被引:25
|
作者
Buer, Jonas Kure [1 ]
机构
[1] Univ Oslo, Dept Social Anthropol, N-0317 Oslo, Norway
关键词
DMARD; SAARD; RID; DC-ART; Drug classes; Rheumatology; History; Anthropology; ACTING ANTIRHEUMATIC DRUGS; REMISSION-INDUCING DRUGS; DISEASE-MODIFYING DRUGS; RHEUMATOID-ARTHRITIS; CLASSIFICATION; THERAPY; SAARDS; AZATHIOPRINE; COMBINATION;
D O I
10.1007/s10787-015-0232-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The article outlines a history of the concept of "disease-modifying antirheumatic drugs" or DMARDs-from the emergence in the 1970s of the idea of drugs with decisive long-term effects on bone erosion in rheumatoid arthritis (RA), through the consolidation and popularisation in the term DMARD in 1980s and 1990s. It then examines the usage of the terms "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs), which for some years offered competition to the term DMARDs, thus underscoring the contingency of the establishment of DMARD as a word. Finally, it juxtaposes the apparently spontaneous emergence of the three terms DMARD, SAARD and RID, and the disappearance of the latter two, with a failed attempt in the early 1990s to replace these terms with the new term "disease-controlling antirheumatic treatment" (DC-ART). The analysis highlights the paradoxical qualities of the DMARD concept as robust albeit tension ridden, while playing down the role of identified individuals and overarching explanations of purpose.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [21] Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate
    ODell, JR
    Haire, C
    Erikson, N
    Drymalski, W
    Palmer, W
    Maloley, P
    Klassen, LW
    Wees, S
    Moore, GF
    JOURNAL OF RHEUMATOLOGY, 1996, 23 : 72 - 74
  • [22] Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis: experience in the ERAN inception cohort
    McWilliams, Daniel F.
    Kiely, Patrick D. W.
    Young, Adam
    Walsh, David A.
    BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [23] Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naive patients with early RA
    Lie, Elisabeth
    Uhlig, Till
    van der Heijde, Desiree
    Rodevand, Erik
    Kalstad, Synove
    Kaufmann, Cecilie
    Mikkelsen, Knut
    Kvien, Tore K.
    RHEUMATOLOGY, 2012, 51 (04) : 670 - 678
  • [24] History of the Term Overactive Bladder""
    Cardona-Grau D.
    Spettel S.
    Current Bladder Dysfunction Reports, 2014, 9 (1) : 48 - 51
  • [25] Importance of psychological well being and disease activity in termination of an initial DMARD therapy
    Listing, J
    Alten, R
    Brauer, D
    Eggens, U
    GromnicaIhle, E
    Hagemann, D
    Hauer, R
    Milleck, D
    Reuter, U
    Schlittgen, R
    Sorensen, H
    Zink, A
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (11) : 2097 - 2105
  • [26] Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use
    Nobunori Takahashi
    Takayoshi Fujibayashi
    Daihei Kida
    Yuji Hirano
    Takefumi Kato
    Daizo Kato
    Kiwamu Saito
    Atsushi Kaneko
    Yuichiro Yabe
    Hideki Takagi
    Takeshi Oguchi
    Hiroyuki Miyake
    Tsuyoshi Watanabe
    Masatoshi Hayashi
    Yasuhide Kanayama
    Koji Funahashi
    Masahiro Hanabayashi
    Shinya Hirabara
    Shuji Asai
    Toki Takemoto
    Kenya Terabe
    Nobuyuki Asai
    Yutaka Yoshioka
    Naoki Ishiguro
    Toshihisa Kojima
    Rheumatology International, 2015, 35 : 1707 - 1716
  • [27] Can we modulate the gut microbiome to enhance DMARD efficacy in rheumatoid arthritis?
    Blank, Rebecca B.
    Nayak, Renuka R.
    Scher, Jose U.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 70
  • [28] This is how I treat patients who need DMARD treatment and have MGUS
    Strunz, Patrick-Pascal
    Schmalzing, Marc
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (05): : 404 - 407
  • [29] Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD users
    Wabe, Nasir
    Lee, Anita
    Wechalekar, Mihir
    McWilliams, Leah
    Proudman, Susanna
    Wiese, Michael
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (06) : 897 - 904
  • [30] Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD users
    Nasir Wabe
    Anita Lee
    Mihir Wechalekar
    Leah McWilliams
    Susanna Proudman
    Michael Wiese
    Rheumatology International, 2017, 37 : 897 - 904